New Publications to Manage Multiple Sclerosis from MSAA

Free Publications Providing Extensive Information Now Available, Including the MS Relapse Toolkit and Understanding Progression in MS The Multiple Sclerosis Association of America (MSAA) has produced two new, free publications, which provide extensive information to the multiple sclerosis (MS) community on MS relapses, as well as progression in MS. The MS Relapse Toolkit is a […]

Read News Article

MSAA Expands MRI Assistance and Helpline Hours

To help meet the escalating demand for MRI assistance, MSAA is pleased to announce new program changes to the MRI Access Fund, which will increase our ability to serve more clients than ever before. Qualified clients can now receive two MRI scans (brain and c-spine) per application as well as reimbursement support for previous MRI […]

Read News Article

FDA Approves Two Doses of Generic Copaxone for MS

On October 4, 2017, Mylan announced that two doses of their generic version of Copaxone® (glatiramer acetate) had been approved by the United States Food and Drug Administration (FDA) for relapsing forms of multiple sclerosis (MS). These two separate treatments include 40 mgs taken three-times weekly and 20 mgs taken once daily, both of which […]

Read News Article

MSAA’s Mobile Phone App, My MS Manager™, Named One of the Best MS Apps of 2017 by Healthline

The Multiple Sclerosis Association of America (MSAA) is proud to announce that our free mobile phone app, My MS Manager™, has been named one of Healthline’s Best Multiple Sclerosis Apps for the fifth consecutive year! Every year, Healthline selects the top apps based on their quality, user reviews, and overall reliability as a source of […]

Read News Article

MSAA’s Magazine, The Motivator, Wins 2017 National Health Information Award

The Multiple Sclerosis Association of America (MSAA) is pleased to announce that we have received an award from the 24th Annual National Health Information Awards! Each year, the National Health Information Awards honors the nation’s best consumer health materials and programs. MSAA received a Merit Award in the Magazine category for The Motivator Summer/Fall 2016 […]

Read News Article

Highlights from the AAN and CMSC 2017 Annual Meetings

During the past few decades, advancements made in multiple sclerosis (MS) research have revolutionized the field. Thus far in 2017, the brisk pace has continued. The American Academy of Neurology (AAN) meeting in April 2017 in Boston, Massachusetts and the Consortium of MS Centers Conference (CMSC) in May 2017 in New Orleans, Louisiana were both […]

Read News Article

MSAA Receives Recognition and an Award for MS Conversations Blog and Changing Lives Monday to Sunday Video

The Multiple Sclerosis Association of America (MSAA) is proud to announce two exciting achievements! MSAA’s MS Conversations blog has been included in Medical News Today’s Best Multiple Sclerosis Blogs feature. Additionally, MSAA’s Changing Lives Monday to Sunday video has been selected as a Spring 2017 Digital Health Awards winner in the Bronze category! The 19th […]

Read News Article

The Multiple Sclerosis Association of America Publishes New Resources

The Multiple Sclerosis Association of America is pleased to announce three new resources for the multiple sclerosis (MS) community. These new publications are available free-of-charge as both printed and online versions on mymsaa.org. MSAA’s award-winning magazine, The Motivator, provides valuable information and support for individuals living with MS, their care partners, family members, and medical […]

Read News Article

FDA Approves myBETAapp and BETACONNECT Navigator

A new mobile and cloud-based health technology offered by Bayer has been approved by the United States Food and Drug Administration (FDA) for individuals taking Betaseron for relapsing-remitting MS. On May 30, 2017, Bayer announced the approval of myBETAapp™ and the BETACONNECT Navigator™. With this software, in conjunction with Bluetooth technology, individuals using the electronic […]

Read News Article